Board of Pharmacy

Helpful Links

• U.S. FDA Purple Book Database of Licensed Biological Products
• Buprenorphine Treatment Guidelines
• Abuse-Deterrent Opioid Analgesics
• DEA Diversion Control Division
• DEA Interim Policy: Multiple Prescriptions
• DEA Pharmacist Manual
• Electronic Code of Federal Regulations
  
• Frequently Asked CSMD Questions (FAQ)
• HIPAA and the Board of Pharmacy
• Information Regarding Approved Biosimilars
• Mandatory Practitioner Profile
• Meth-Free Tennessee Act of 2005
  
• New Gabapentin Law Effective July 1, 2018
• Patients and health care providers can learn about postmarket drug safety information
• Prescription Writing Format for Nurse Practitioners
• U.S. Food & Drug Administration
• Volunteer for Mass Emergency Clinics

Drug Disposal Locations

• Drug Disposal – safe.pharmacy
• Controlled Substance Public Disposal Location - usdoj/gov
• To subscribe to the Tennessee Board of Pharmacy Newsletter Alert e-mail list, go the link below for past               letters and to add yourself to the mailing list:  https://nabp.pharmacy/bop_members/tennessee/